AlembicPharmaceuticals gets USFDA nod for ophthalmic solution

AlembicPharmaceuticals gets USFDA nod for ophthalmic solution

Monday, December 10, 2018

Drug firm Alembic Pharmaceuticals Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic solution, used to treat allergic conjunctivitis.

For more information on Indian Share Market Tips For Tomorrow

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »